LEXINGTON, Mass.--(BUSINESS WIRE)--Apr. 25, 2019--
Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will
report its first quarter 2019 financial results on Thursday, May 2,
2019, before the U.S. financial markets open. The Company will host a
conference call and webcast at 8:30 a.m. ET to discuss first quarter
financial results and provide a business update. Individuals interested
in participating in the call should dial (855) 354-1855 (U.S. and
Canada) or (484) 365-2865 (International).
A live webcast of the first quarter financial results may be accessed in
section of the Company’s website at www.concertpharma.com.
Please log on to the Concert website approximately 15 minutes prior to
the scheduled webcast to ensure adequate time for any software downloads
that may be required. A replay of the first quarter financial results
webcast will be available on Concert’s website for three months.
Pharmaceuticals is a clinical stage biopharmaceutical company
focused on applying its DCE
Platform® (deuterated chemical entity platform) to create novel
medicines designed to treat serious diseases and address unmet patient
needs. The Company’s approach starts with previously studied compounds,
including approved drugs, in which deuterium substitution has the
potential to enhance clinical safety, tolerability or efficacy.
Concert’s pipeline of
innovative medicines targets autoimmune diseases and central nervous
systems (CNS) disorders. For more information please visit www.concertpharma.com
or follow us on Twitter at @ConcertPharma
or on LinkedIn.
Concert Pharmaceuticals Inc., the CoNCERT Pharmaceuticals Inc. logo and
DCE Platform are registered trademarks of Concert Pharmaceuticals, Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190425005082/en/
Source: Concert Pharmaceuticals, Inc.